5.800
+0,00%
2026-10-19
Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +115.7% | +53.1% | 3 / 3 | +39.2% | +13.42 pp | +165.21 pp | -62.5% | 10.39 | — | 164 | +39,2% | 27,3 | +115,7% | — | -5.80 | — |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 5.800 (close price on 2026-10-19)EPS (TTM): −688,2
Financial charts
1.Revenue & growth
VND bn164Q2/26
1.Revenue & growth
VND bn164Q2/26
2.Profit & growth
VND bn27,3Q2/26
3.Profit mix (Penman)
VND bn-756Q2/26
4.Margins & cost structure
%24.2%Q2/26
5.Returns & cash cycle
% · days0.9%Q2/26
6.Earnings quality & cash
VND bn1.411Q2/26
7.Asset structure
VND bn22.049Q2/26
8.Funding & debt health
VND bn · times22.049Q2/26
9.Revenue backlog
VND bn4.888Q2/26
10.Valuation
times · %-9,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %25Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26